The vaginal pessary market includes vaginal inserts that are introduced into the vagina to treat medical conditions such as pelvic organ prolapse. Vaginal pessaries come in various shapes and sizes depending on the nature of Pelvic organ prolapse. They support the pelvic organs and walls by preventing further dropping or slipping down. The increasing prevalence of pelvic organ prolapse and growing medical tourism in developing economies are fueling the demand for vaginal pessaries.
The Global Vaginal Pessary Market is estimated to be valued at US$ 411.68 Mn in 2024 and is expected to exhibit a CAGR of 8.3% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the vaginal pessary market are Arakawa Chemical Industries, Eastman Chemical Company, Exxon Mobil Corporation, Ltd., Kolon Industries, Inc., Lesco Chemical Limited, Zeon Corporation, Seacon Corporation, Neville Chemical Company, Total Cray Valley, and Anglxxon Chemical Co., Ltd. The increasing geriatric population is leading to high risk of pelvic organ prolapse, which is driving the demand for vaginal pessaries. Major players are expanding their geographical presence in emerging markets to tap the growth opportunities.
Market key trends
One of the key trends witnessed in the Vaginal Pessary Market Demand is the growing applications in chronic disease management. Vaginal pessaries are gaining more focus in managing pelvic organ prolapse, urinary incontinence, and other chronic gynecological conditions. This is facilitating innovations to develop more effective and comfortable product variants. Startups and large companies are investing heavily in R&D to introduce novel vaginal pessary designs catering to unmet needs of women populations.
Porter’s Analysis
Threat of new entrants: Low as there is a need for high capital investment and established distribution channels.
Bargaining power of buyers: Moderate as there are many established brands but switching costs for buyers are low.
Bargaining power of suppliers: Moderate as raw materials can be sourced easily but suppliers may bargain for higher prices due to established product demand.
Threat of new substitutes: Low as there are limited substitutes that can effectively address pelvic organ prolapse.
Competitive rivalry: High among key brands to gain more market share.
Geographical Regions
North America accounts for the largest share of the vaginal pessary market currently, owing to the increasing incidence of pelvic organ prolapse conditions among women. According to the US National Library of Medicine, pelvic organ prolapse affects up to 50% of women who have had children.
The Asia Pacific region is expected to witness the highest growth during the forecast period due to growing awareness about women’s health issues, increasing disposable incomes, and expanding healthcare infrastructure and services in emerging countries such as China and India.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it